Published in:
01-01-2008 | Update
Journal Watch
Published in: Pharmaceutical Medicine | Issue 1/2008
Login to get accessExcerpt
-
1. Optimizing Therapy with Antibacterial Agents: Use of Pharmacokinetic-Pharmacodynamic Principles in Pediatrics
-
2. Economic Evidence at the Local Level: Options for Making it More Useful
-
3. Intelligent Risk Communication: Can it be Improved?
-
4. Biotherapeutics in the Era of Biosimilars: What Really Matters is Patient Safety
-
5. Biosimilar Drugs: Concerns and Opportunities
-
6. NICE Cost-Effectiveness Appraisal of Cholinesterase Inhibitors: Was the Right Question Posed? Were the Best Tools Used?
-
7. Cardiac Repolarisation and Drug Regulation: Assessing Cardiac Safety 10 Years after the CPMP Guidance
-
8. Methods for Causality Assessment of Adverse Drug Reactions: A Systematic Review
-
9. Antiarrhythmics: Elimination and Dosage Considerations in Hepatic Impairment
-
10. The Last Decade of Italian Pharmaceutical Policy: Instability or Consolidation?
-
11. Data Resources for Investigating Drug Exposure during Pregnancy and Associated Outcomes: The General Practice Research Database (GPRD) as an Alternative to Pregnancy Registries
-
12. Anticancer Therapy Targeting Telomeres and Telomerase: Current Status
-
13. Detection of Spironolactone-Associated Hyperkalaemia Following the Randomized Aldactone Evaluation Study (RALES)
-
14. Role of P-Glycoprotein Inhibition for Drug Interactions: Evidence from In Vitro and Pharmacoepidemiological Studies
-
15. Predicting Oral Clearance in Humans: How Close Can We Get with Allometry?
-
16. Analysis of Severe Hepatic Events Associated with Nevirapine-Containing Regimens: CD4+ T-Cell Count and Gender in Hepatitis C Seropositive and Seronegative Patients
-
17. Dynamic Modelling of Infectious Diseases: An Application to the Economic Evaluation of Influenza Vaccination